Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014735
Filing Date
2024-11-07
Accepted
2024-11-07 06:05:45
Documents
94
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q drio-20240930x10q.htm   iXBRL 10-Q 2501190
2 EX-31.1 drio-20240930xex31d1.htm EX-31.1 10278
3 EX-31.2 drio-20240930xex31d2.htm EX-31.2 10270
4 EX-32.1 drio-20240930xex32d1.htm EX-32.1 6883
5 EX-32.2 drio-20240930xex32d2.htm EX-32.2 6917
  Complete submission text file 0001558370-24-014735.txt   11756795

Data Files

Seq Description Document Type Size
6 EX-101.SCH drio-20240930.xsd EX-101.SCH 73922
7 EX-101.CAL drio-20240930_cal.xml EX-101.CAL 64488
8 EX-101.DEF drio-20240930_def.xml EX-101.DEF 317914
9 EX-101.LAB drio-20240930_lab.xml EX-101.LAB 619739
10 EX-101.PRE drio-20240930_pre.xml EX-101.PRE 507398
97 EXTRACTED XBRL INSTANCE DOCUMENT drio-20240930x10q_htm.xml XML 2538080
Mailing Address 322 W 57TH ST. #33B NEW YORK NY 10019
Business Address 322 W 57TH ST. #33B NEW YORK NY 10019 972-4-770-6377
DarioHealth Corp. (Filer) CIK: 0001533998 (see all company filings)

EIN.: 452973162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37704 | Film No.: 241432888
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)